Editors’ Picks, March 2026: Pediatric Leukemia Development, Low-dose Tamoxifen Use, and More
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In February, the editors of AACR's journals highlighted studies on the FDA’s accelerated approval pathway, how metabolism impacts prostate...
The AACR, The Mark Foundation, Lustgarten Foundation, Break Through Cancer, and Tina’s Wish will explore early detection approaches for...
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power...
The countdown to the new year is nearly upon us, but no need to count down to the last...
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...